Wellington Management Group LLP Purchases 1,094 Shares of Henry Schein, Inc. $HSIC

Wellington Management Group LLP increased its position in Henry Schein, Inc. (NASDAQ:HSIC) by 15.9% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 7,996 shares of the company’s stock after purchasing an additional 1,094 shares during the period. Wellington Management Group LLP’s holdings in Henry Schein were worth $548,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also bought and sold shares of HSIC. JPMorgan Chase & Co. boosted its holdings in shares of Henry Schein by 6.5% during the 1st quarter. JPMorgan Chase & Co. now owns 6,373,036 shares of the company’s stock valued at $436,489,000 after acquiring an additional 390,399 shares during the last quarter. Dimensional Fund Advisors LP boosted its holdings in shares of Henry Schein by 4.8% during the 1st quarter. Dimensional Fund Advisors LP now owns 2,240,933 shares of the company’s stock valued at $153,480,000 after acquiring an additional 103,384 shares during the last quarter. Burgundy Asset Management Ltd. boosted its holdings in shares of Henry Schein by 33.9% during the 1st quarter. Burgundy Asset Management Ltd. now owns 2,235,429 shares of the company’s stock valued at $153,105,000 after acquiring an additional 566,530 shares during the last quarter. Steadfast Capital Management LP boosted its holdings in shares of Henry Schein by 254.2% during the 4th quarter. Steadfast Capital Management LP now owns 1,637,808 shares of the company’s stock valued at $113,336,000 after acquiring an additional 1,175,408 shares during the last quarter. Finally, Hudson Bay Capital Management LP boosted its holdings in shares of Henry Schein by 102.1% during the 4th quarter. Hudson Bay Capital Management LP now owns 1,465,007 shares of the company’s stock valued at $101,378,000 after acquiring an additional 740,007 shares during the last quarter. Institutional investors own 96.62% of the company’s stock.

Henry Schein Stock Performance

HSIC opened at $69.58 on Tuesday. The company has a current ratio of 1.41, a quick ratio of 0.78 and a debt-to-equity ratio of 0.51. The company has a market cap of $8.44 billion, a price-to-earnings ratio of 22.45, a PEG ratio of 2.30 and a beta of 0.86. The company’s 50 day moving average is $70.31 and its 200 day moving average is $69.94. Henry Schein, Inc. has a 12-month low of $60.56 and a 12-month high of $82.49.

Henry Schein (NASDAQ:HSIC) last posted its quarterly earnings data on Tuesday, August 5th. The company reported $1.10 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.19 by ($0.09). Henry Schein had a return on equity of 14.36% and a net margin of 3.05%.The business had revenue of $3.24 billion during the quarter, compared to analysts’ expectations of $3.22 billion. During the same period in the previous year, the business posted $1.23 EPS. The business’s quarterly revenue was up 3.3% compared to the same quarter last year. Henry Schein has set its FY 2025 guidance at 4.800-4.940 EPS. On average, equities research analysts predict that Henry Schein, Inc. will post 4.74 EPS for the current year.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on the stock. Stifel Nicolaus reaffirmed a “hold” rating and set a $75.00 price target (down previously from $80.00) on shares of Henry Schein in a report on Friday, July 25th. Barrington Research dropped their price target on shares of Henry Schein from $86.00 to $78.00 and set an “outperform” rating on the stock in a report on Wednesday, August 6th. Wall Street Zen raised shares of Henry Schein from a “hold” rating to a “buy” rating in a report on Saturday. Robert W. Baird reissued a “neutral” rating and issued a $72.00 price objective (down previously from $82.00) on shares of Henry Schein in a report on Monday, July 14th. Finally, Wells Fargo & Company dropped their price objective on shares of Henry Schein from $80.00 to $75.00 and set an “equal weight” rating on the stock in a report on Tuesday, May 6th. Five equities research analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat.com, Henry Schein currently has an average rating of “Hold” and a consensus price target of $76.67.

About Henry Schein

Henry Schein, Inc provides health care products and services to dental practitioners, laboratories, physician practices, and ambulatory surgery centers, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.